In this issue of AAPS Journal, Xiaohong Qi presents a stochastic version of an existing pharmacodynamic model for glucocorticoid action proposed by Jusko and colleagues (Qi X. A Stochastic Version of Corticosteriod Pharmacogenomic Model. AAPS Journal. 2005; 07(13): E134-E140). The salient contribution of the paper is the use of the Gillespie method, which recasts deterministic differential equation-based models into a stochastic framework, replacing numerical integration of the model differential equations with Monte Carlo simulation. Although deterministic differential equations have been the mainstay of pharmacokinetic and pharmacodynamic (PK/PD) modeling, the stochastic framework is in fact more fundamental. The microscopic processes underlying transport and chemical reactions, including molecular diffusion and the surmounting of activation energy barriers, are subject to random thermal fluctuations and are, therefore, stochastic. In the limit where the number of molecules, cells, or "copies" of the species of interest in a PK/PD system is large, these random fluctuations are of negligible magnitude compared with the average copy numbers, and the deterministic description provides an approximation with negligible error. On the other hand, the deterministic description can lose its validity when the copy number becomes small: this is often of relevance in the small volume of the cell and in the lower limiting behaviors of "large" systems Explicit functions describing stochastic behaviors are rarely possible, and the Gillespie method efficiently generates specific realizations of the events occurring in stochastic models. Each realization obtained using the Gillespie method corresponds to the time series of copy numbers of a species in a single cell or individual. By generating multiple realizations of the time series in numerous simulated cells/individuals, a stochastic characterization of population dynamics is possible. As expected, when the copy numbers are large, the averages from the stochastic approach closely mimic behaviors that would be predicted by a deterministic model. However, when copy numbers of critical species are small, very different behaviors may be observed in different cells/individuals, even though the underlying rules governing reactions in each cell are the same. The likelihood of unexpected behaviors is increased when the model involves nonlinear components such as bimolecular reactions, saturability, and cooperative transitions.
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We use the following simple model of the bactericidal action of an antibiotic to illustrate difficulties in using a deterministic description when copy number is small.
The effect of an antibiotic on bacterial growth kinetics might be modeled deterministically by a differential equation as follows:
where n is the number of bacteria, k rep ≥ 0 is a first-order rate constant associated with bacterial replication, and k kill (C) ≥ 0 is a pseudo-first-order, drug-concentration-dependent rate constant for killing of bacteria. This model predicts a continuous decrease in bacterial count with time when the term in the brackets is negative and continuous bacterial growth when the term is positive. However, in reality, each bacterial division or death causes discrete changes in n occurring at random times, and on close inspection, a plot of the exact time series of bacterial count will appear as a sequence of unit step changes occurring at randomly distributed time intervals. When n is large, an apparently smooth decay or growth curve is obtained, and the fact that the deterministic model leads to noninteger values of n is of little consequence.
Suppose now that because of sufficient exposure to antibiotic, the average bacterial count is very low and that any available antibiotic concentration is no longer effective. Suppose further that because of the low average bacterial count, there is either 1 or 0 bacteria remaining in each individual being modeled. In the former case, replication of the single remaining bacterium provides the possibility for eventual exponential growth kinetics. In the latter case, all bacteria are killed and the bacterial count will be zero ad infinitum. The deterministic model predicts only one behavior-exponential regrowth of the bacteria population-for this model situation. In the stochastic model, however, n will correctly remain zero forever in individuals whose bacterial count reaches 0, and n may take on a distribution of positive values, including 0, at subsequent times in individuals with nonzero bacterial counts. Under such conditions, the stochastic description is essential because the deterministic differential equation approach breaks down and fails to crisply predict the existence of these 2 possibilities, which can lead to very different pharmaceutical outcomes.
The lessons learned from this simple bacterial/antibiotic example also carry over to simulations of genomic processes E141 E142 in mammalian cells. There is emerging evidence that stochastic fluctuations may be prominent in gene expression and the resultant phenotypic outcomes. Because there are (usually) only 2 copies of each gene-one from each parent-in each mammalian cell at most genetic loci (exceptions include genes residing on the sex chromosomes and the few genes that have undergone gene duplications), stochastic variations in transcription factor binding and unbinding can cause variations in promoter occupancy and at a given time, both, 1, or none of the 2 gene copies may be activated (or repressed). The result will be noisy temporal variations in gene expression within each cell and/or heterogeneity in gene expression between cells. The limited availability of transcription factors and the short half-life of mRNAs may add further to the inherent stochasticity of gene expression in a cell. Although Qi's report does not directly address these underlying mechanistic genetic/genomic issues, the introduction of Gillespie algorithm-based stochastic simulation technique to the pharmaceutical sciences is important because there are many identifiable questions for which the stochastic simulation approach can be expected to provide more useful information than the traditional deterministic approach. We believe that the true power of the stochastic approach lies in its ability to probe the full spectrum of PK/PD profiles that are compatible with a particular kinetic scheme. Since important pharmaceutical outcomes in populations and dynamic phenomena in cells (eg, switching to carcinogenic or metastatic phenotypes, decisions to proliferate or undergo cell death/apoptosis) can occur at the "fringes" of the distributions of molecular states in a cell, it is important to have at our disposal techniques that can predict the frequency with which PK/PD trajectories intersect such fringe regions.
